Transcriptional Signatures of the BCL2 Family for Individualized Acute Myeloid Leukemia Treatment

From three AML RNA-seq cohorts, scientists constructed the B cell lymphoma-2 (BCL2) family signatures by applying an innovative gene-set selection method reflecting biological knowledge followed by non-negative matrix factorization.